Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00880152 · ClinicalTrials.gov registry record · NA

Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder: A Pilot Study

A NA study of Depression and Stress Disorders, Post-Traumatic, sponsored by Seattle Institute for Biomedical and Clinical Research.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT00880152: Completed NA study of Depression and Stress Disorders, Post-Traumatic, sponsored by Seattle Institute for Biomedical and Clinical Research.

NCT00880152 is a NA study of Depression and Stress Disorders, Post-Traumatic that has completed, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 50 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00880152, a NA study of Depression and Stress Disorders, Post-Traumatic, has completed, sponsored by Seattle Institute for Biomedical and Clinical Research.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

PTSD is a common consequence of war, for soldiers and civilians. PTSD results in hyperarousal, avoidance, numbing, and re-experiencing, causing persistent decreased quality of life. Mindfulness involves the ability to bring attention to the present moment without judgment; this ability is correlated with measures of mental health. Within health care, mindfulness is taught as an 8-week course called Mindfulness-Based Stress Reduction (MBSR). MBSR is unstudied for PTSD. We propose to assess the feasibility of MBSR as an intervention for PTSD, since it may affect hypervigilance, avoidance, and reactivity associated with this disorder. Specific Aims: Aim 1: Assess the feasibility of recruiting and retaining a sample of veterans with PTSD to complete a study protocol that involves randomization to usual care or usual care plus MBSR. Aim 2: Apply measures of PTSD symptom severity, depression and quality of life before and after randomization, to assess whether there is evidence of benefit and whether MBSR warrants further study for PTSD, and allow calculation of standardized effect sizes. Aim 3: Apply a validated measure of mindfulness before and after treatment. Aim 4: Explore the relationship between PTSD symptoms, mindfulness score, and frequency of meditation practice.

Interventions

  • BEHAVIORAL Mindfulness-based stress reduction

Study Locations (1)

Washington

  • VA Puget Sound Health Care System - Seattle

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2008-09
Est. Completion 2009-12
Phase NA

What the finished NCT00880152 record still lists

NCT00880152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower).

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness-based stress reduction is the first listed.

NCT00880152 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT00880152 about?

NCT00880152 is a clinical study titled "Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder: A Pilot Study". PTSD is a common consequence of war, for soldiers and civilians. PTSD results in hyperarousal, avoidance, numbing, and re-experiencing, causing persistent decreased quality of life. Mindfulness involves the ability to bring attention to the present moment without judgment; this ability is correlated...

What is the current status of trial NCT00880152?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2008-09. Estimated completion is 2009-12.

What conditions does trial NCT00880152 study?

This clinical trial studies the following conditions: Depression, Stress Disorders, Post-Traumatic.

What interventions are being tested in trial NCT00880152?

The interventions under investigation include: Mindfulness-based stress reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT00880152?

This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00880152 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00880152's enrollment target sits among peer trials

50 468th of 679 higher than 199 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00880152, the US trial registry maintained by the National Library of Medicine. NCT00880152 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.